Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $3.3 million.

  • Cellebrite DI's Net Cash Flow rose 258.88% to $102.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.1 million, marking a year-over-year increase of 7762.50%. This contributed to the annual value of $3.3 million for FY2024, which is 96.69% down from last year.
  • Cellebrite DI's Net Cash Flow amounted to $3.3 million in FY2024, which was down 96.69% from $101.3 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Net Cash Flow ranged from a high of $101.3 million in FY2023 and a low of -$56.7 million during FY2022.
  • In the last 3 years, Cellebrite DI's Net Cash Flow had a median value of $3.3 million in 2024 and averaged $16.0 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 540.06% in 2022, then spiked by 278.68% in 2023.
  • Over the past 5 years, Cellebrite DI's Net Cash Flow (Yearly) stood at $51.5 million in 2020, then plummeted by 74.97% to $12.9 million in 2021, then plummeted by 540.06% to -$56.7 million in 2022, then soared by 278.68% to $101.3 million in 2023, then slumped by 96.69% to $3.3 million in 2024.